NCT04188821

Brief Summary

The experimental hypothesis of this randomized controlled study was to demonstrate that early drain removal in patients who underwent immediate breast reconstruction with tissue expander is a safety procedure to improving clinical outcomes and quality of life (QoL). The mechanism of action underlying the proposed approach was intuitive. The early drain removal allows to: 1) avoid continuous seroma development caused by active suction of drain (stopping the circle "drain itself may perpetuate the drainage" with vacuum mechanism); 2) reduce the risks connected to "foreign body reaction" as tissue inflammation and infection; 3) improve QoL reducing pain, length of hospital stay and limitations of daily activities.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 6, 2019

Completed
Last Updated

December 10, 2019

Status Verified

December 1, 2019

Enrollment Period

1.6 years

First QC Date

November 28, 2019

Last Update Submit

December 6, 2019

Conditions

Outcome Measures

Primary Outcomes (6)

  • total fluid volume (ml)

    sum of drain volumes and volume of seroma aspirations if needed

    21 days

  • days with drainage

    21 days

  • days of seroma formation

    period that drain or seroma aspiration is needed in days after surgery

    21 days

  • time until wound healing (days)

    21 days

  • infection (yes or not)

    defined as the appearance of local signs/symptoms as erythema, edema, induration, increased pain, and a change in drainage to a purulent nature and fever, confirmed by swabs

    21 days

  • complicated wound healing (yes or not)

    unclosed wound 3 weeks postoperatively

    21 days

Secondary Outcomes (4)

  • pain (using Visual Analogic Score scale to measure intensity)

    21 days

  • disturbance in quality of sleep (yes or not)

    21 days

  • limitation in personal care, daily activities and social life (yes or not)

    21 days

  • disturbance in mobility (yes or not)

    21 days

Study Arms (2)

output based group

ACTIVE COMPARATOR

Investigators remove the drains when the suction drain flow was less than 30 ml/day for at least 2 days with no further signs of infection, fluid collection or impaired wound healing

Procedure: breast drain removal

early-removal group

EXPERIMENTAL

Investigators remove the drains at hospital discharge, 3-4 days after surgery, regardless of the output at that time

Procedure: breast drain removal

Interventions

Investigators remove the drains when the suction drain flow was less than 30 ml/day for at least 2 days or at discharge, with no further signs of infection, fluid collection or impaired wound healing ("complicated", see below). Ultimately, we removed drains 3 weeks postoperatively (21 days post op) even if the flow was higher than 30 ml/day. However, leakage or severe patient discomfort led to immediate drain removal at any time during postoperative care.

early-removal groupoutput based group

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SNS (skin nipple sparing) or SS (skin sparing) mastectomy for breast cancer and immediate positioning of breast expander (without mesh) with placement of suction drain, regardless of TNM classification

You may not qualify if:

  • skin reducing mastectomy, reconstruction with flap, direct to implant reconstruction (with or without mesh or ADM) and axillary dissection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 28, 2019

First Posted

December 6, 2019

Study Start

September 1, 2016

Primary Completion

March 31, 2018

Study Completion

December 31, 2018

Last Updated

December 10, 2019

Record last verified: 2019-12